메뉴 건너뛰기




Volumn 112, Issue 5 SUPPL., 2003, Pages

The role of botulinum toxin type B (Myobloc) in the treatment of hyperkinetic facial lines

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN A; BOTULINUM TOXIN B; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; BOTULINUM TOXIN;

EID: 0142248784     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000082197.88799.84     Document Type: Article
Times cited : (16)

References (18)
  • 1
    • 0029396980 scopus 로고
    • Botulinum toxin type B in the treatment of cervical dystonia: A pilot study
    • Tsui, J. K., Hayward, M., Mak, E. K., et al. Botulinum toxin type B in the treatment of cervical dystonia: A pilot study. Neurology 45: 2109, 1995.
    • (1995) Neurology , vol.45 , pp. 2109
    • Tsui, J.K.1    Hayward, M.2    Mak, E.K.3
  • 2
    • 0030853667 scopus 로고    scopus 로고
    • Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia
    • Lew, M. F., Adornato, B. T., Duane, D. D., et al. Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology 49: 701, 1997.
    • (1997) Neurology , vol.49 , pp. 701
    • Lew, M.F.1    Adornato, B.T.2    Duane, D.D.3
  • 3
    • 0034719053 scopus 로고    scopus 로고
    • The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: Summary of three controlled clinical trials
    • Lew, M. F., Brashear, A., and Factor, S. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: Summary of three controlled clinical trials. Neurology 55: S29, 2000.
    • (2000) Neurology , vol.55
    • Lew, M.F.1    Brashear, A.2    Factor, S.3
  • 4
    • 0032718516 scopus 로고    scopus 로고
    • Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia
    • Brashear, A., Lew, M. F., Dykstra, D. D., et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 53: 1439, 1999.
    • (1999) Neurology , vol.53 , pp. 1439
    • Brashear, A.1    Lew, M.F.2    Dykstra, D.D.3
  • 5
    • 0034719038 scopus 로고    scopus 로고
    • The biochemistry of botulinum toxin type B
    • Setler, P. The biochemistry of botulinum toxin type B. Neurology 55: S22, 2000.
    • (2000) Neurology , vol.55
    • Setler, P.1
  • 6
    • 0035130709 scopus 로고    scopus 로고
    • Botulinum toxin: Basic science and clinical uses in otolaryngology
    • Blitzer, A., and Sulica, L. Botulinum toxin: Basic science and clinical uses in otolaryngology. Laryngoscope 111: 218, 2001.
    • (2001) Laryngoscope , vol.111 , pp. 218
    • Blitzer, A.1    Sulica, L.2
  • 7
    • 33748271738 scopus 로고    scopus 로고
    • Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology
    • Brin, M. F. Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl. 6: S146, 1997.
    • (1997) Muscle Nerve Suppl. , vol.6
    • Brin, M.F.1
  • 8
    • 0034918865 scopus 로고    scopus 로고
    • Botulinum toxin type B: An overview of its biochemistry and preclinical pharmacology
    • Callaway, J. E., Arezzo, J. C., and Grethlein, A. J. Botulinum toxin type B: An overview of its biochemistry and preclinical pharmacology. Semin. Cutan. Med. Surg. 20: 127, 2001.
    • (2001) Semin. Cutan. Med. Surg. , vol.20 , pp. 127
    • Callaway, J.E.1    Arezzo, J.C.2    Grethlein, A.J.3
  • 9
    • 0036560715 scopus 로고    scopus 로고
    • Botulinum toxin type B (MyoBloc) in the management of hyperkinetic facial lines
    • Ramirez, A. L., Reeck, J., and Maas, C. S. Botulinum toxin type B (MyoBloc) in the management of hyperkinetic facial lines. Otolaryngol. Head Neck Surg. 126: 459, 2002.
    • (2002) Otolaryngol. Head Neck Surg. , vol.126 , pp. 459
    • Ramirez, A.L.1    Reeck, J.2    Maas, C.S.3
  • 10
    • 0028016230 scopus 로고
    • Botulinum toxin A for hyperkinetic facial lines: Results of a double-blind, placebo-controlled study
    • Keen, M., Blitzer, A., Aviv, J., et al. Botulinum toxin A for hyperkinetic facial lines: Results of a double-blind, placebo-controlled study. Plast. Reconstr. Surg. 94: 94, 1994.
    • (1994) Plast. Reconstr. Surg. , vol.94 , pp. 94
    • Keen, M.1    Blitzer, A.2    Aviv, J.3
  • 11
    • 0030481450 scopus 로고    scopus 로고
    • Botulinum A exotoxin for glabellar folds: A double-blind, placebo-controlled study with an electromyographic injection technique
    • Lowe, N.J., Maxwell, A., and Harper, H. Botulinum A exotoxin for glabellar folds: A double-blind, placebo-controlled study with an electromyographic injection technique. J. Am. Acad. Dermatol. 35: 569, 1996.
    • (1996) J. Am. Acad. Dermatol. , vol.35 , pp. 569
    • Lowe, N.J.1    Maxwell, A.2    Harper, H.3
  • 12
    • 0029981227 scopus 로고    scopus 로고
    • The use of botulinum A toxin to ameliorate facial kinetic frown lines
    • Foster, J. A., Barnhorst, D., Papay, F., et al. The use of botulinum A toxin to ameliorate facial kinetic frown lines. Ophthalmology 103: 618, 1996.
    • (1996) Ophthalmology , vol.103 , pp. 618
    • Foster, J.A.1    Barnhorst, D.2    Papay, F.3
  • 13
    • 0030963474 scopus 로고    scopus 로고
    • The management of hyperfunctional facial lines with botulinum toxin: A collaborative study of 210 injection sites in 162 patients
    • Blitzer, A., Binder, W. J., Aviv, J. E., et al. The management of hyperfunctional facial lines with botulinum toxin: A collaborative study of 210 injection sites in 162 patients. Arch. Otolaryngol. Head Neck Surg. 123: 389, 1997.
    • (1997) Arch. Otolaryngol. Head Neck Surg. , vol.123 , pp. 389
    • Blitzer, A.1    Binder, W.J.2    Aviv, J.E.3
  • 14
    • 33750886088 scopus 로고    scopus 로고
    • Radiated scale for evaluation of hyperkinetic lines
    • in press
    • Kim, E. J., et al. Radiated scale for evaluation of hyperkinetic lines. Arch. Facial Plast. Surg. (in press).
    • Arch. Facial Plast. Surg.
    • Kim, E.J.1
  • 15
    • 0034576744 scopus 로고    scopus 로고
    • Measuring injection-site pain associated with vaccine administration in adults: A randomised, double-blind, placebo-controlled clinical trial
    • Su, L., Tucker, R., Frey, S. E., et al. Measuring injection-site pain associated with vaccine administration in adults: A randomised, double-blind, placebo-controlled clinical trial. J. Epidemiol. Biostat. 5: 359, 2000.
    • (2000) J. Epidemiol. Biostat. , vol.5 , pp. 359
    • Su, L.1    Tucker, R.2    Frey, S.E.3
  • 17
    • 0025989861 scopus 로고
    • Quantifying the spread of botulinum toxin through muscle fascia
    • Shaari, C. M., George, E., Wu, B. L., et al. Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope 101: 960, 1991.
    • (1991) Laryngoscope , vol.101 , pp. 960
    • Shaari, C.M.1    George, E.2    Wu, B.L.3
  • 18
    • 0027976367 scopus 로고
    • Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections
    • Borodic, G. E., Ferrante, R., Pearce, L. B., et al. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov. Disord. 9: 31, 1994.
    • (1994) Mov. Disord. , vol.9 , pp. 31
    • Borodic, G.E.1    Ferrante, R.2    Pearce, L.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.